685 related articles for article (PubMed ID: 16759341)
1. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
[TBL] [Abstract][Full Text] [Related]
2. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.
Schluger JH; Borg L; Ho A; Kreek MJ
Neuropsychopharmacology; 2001 May; 24(5):568-75. PubMed ID: 11282257
[TBL] [Abstract][Full Text] [Related]
3. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
Nava F; Manzato E; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.
Schluger JH; Bart G; Green M; Ho A; Kreek MJ
Neuropsychopharmacology; 2003 May; 28(5):985-94. PubMed ID: 12700714
[TBL] [Abstract][Full Text] [Related]
5. The low-dose dexamethasone suppression test in fibromyalgia.
Wingenfeld K; Wagner D; Schmidt I; Meinlschmidt G; Hellhammer DH; Heim C
J Psychosom Res; 2007 Jan; 62(1):85-91. PubMed ID: 17188125
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
[TBL] [Abstract][Full Text] [Related]
7. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
Wilson ME; Fisher J; Brown J
Physiol Behav; 2005 Mar; 84(3):449-58. PubMed ID: 15763583
[TBL] [Abstract][Full Text] [Related]
8. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
[TBL] [Abstract][Full Text] [Related]
9. Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients.
Gerra G; Leonardi C; Cortese E; Zaimovic A; Dell'Agnello G; Manfredini M; Somaini L; Petracca F; Caretti V; Baroni C; Donnini C
Addict Biol; 2008 Mar; 13(1):95-104. PubMed ID: 18201294
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence.
Zhang GF; Ren YP; Sheng LX; Chi Y; Du WJ; Guo S; Jiang ZN; Xiao L; Luo XN; Tang YL; Smith AK; Liu ZQ; Zhang HX
Am J Drug Alcohol Abuse; 2008; 34(6):760-8. PubMed ID: 19016181
[TBL] [Abstract][Full Text] [Related]
11. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.
Nava F; Caldiroli E; Premi S; Lucchini A
J Addict Dis; 2006; 25(2):9-16. PubMed ID: 16785214
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of the hypothalamic-pituitary-adrenal system of pigeons (Columba livia domestica) to suppression by dexamethasone, cortisol, and prednisolone.
Westerhof I; Van den Brom WE; Mol JA; Lumeij JT; Rijnberk A
Avian Dis; 1994; 38(3):435-45. PubMed ID: 7832695
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ
J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442
[TBL] [Abstract][Full Text] [Related]
15. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
[TBL] [Abstract][Full Text] [Related]
16. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
17. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.
Ströhle A; Scheel M; Modell S; Holsboer F
J Psychiatr Res; 2008 Oct; 42(14):1185-8. PubMed ID: 18342888
[TBL] [Abstract][Full Text] [Related]
18. Biology of posttraumatic stress disorder.
Yehuda R
J Clin Psychiatry; 2001; 62 Suppl 17():41-6. PubMed ID: 11495096
[TBL] [Abstract][Full Text] [Related]
19. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
20. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]